. | . |
China back to 'normal' after end of Covid curbs: official by AFP Staff Writers Davos, Switzerland (AFP) Jan 17, 2023 China has returned to normal after the lifting of Covid-19 restrictions, Vice Premier Liu He told the World Economic Forum on Tuesday as he invited "international friends" to visit the country. China abruptly dropped its "zero-Covid" approach last month after three years of enforcing some of the harshest anti-pandemic restrictions in the world. The move led to a wave of infections that packed hospitals and overwhelmed crematoriums, with authorities revealing Saturday that almost 60,000 Covid-related deaths were reported in just over a month. But Liu told the meeting of the global elite in the Swiss Alpine village of Davos that the transition "has overall been stable and smooth". "The time to reach the peak (of infections) and to return to normal has been relatively fast. In some senses, it has exceeded our expectations," he said. Liu said the food and beverage industry and tourism had started to return to normal, with five billion trips expected during China's Lunar New Year holiday that begins this weekend. "Things have comprehensively returned to normal," he said. "Currently the main difficulty is still the elderly, those with underlying conditions," he said, adding: "We are currently striving to tackle this." Millions of the elderly in China are not fully vaccinated, with President Xi Jinping's government criticised for not prioritising immunisation campaigns among the country's most vulnerable citizens. Liu also encouraged foreigners to visit China after quarantine requirements for overseas arrivals were dropped last week. "We very much welcome international friends to come to China. We will provide the best service. Of course, right now, on some issues we need some time to transition, but on the whole, there is already no problem," he said.
Teams selected to develop vaccine durability prediction tools Washington DC (SPX) Jan 15, 2023 According to recent studies cited in Science Magazine, many vaccines - including those for flu, mumps and other diseases - may lose their effectiveness faster than official immunization recommendations suggest1. DARPA has selected teams of researchers to support the Assessing Immune Memory (AIM) program, which seeks to develop a research and evaluation tool that can predict early on whether a given vaccine candidate will provide long-lasting immune protection. Warfighters must deploy to regions of ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |